Cancer-associated genodermatoses: skin neoplasms as clues to hereditary tumor syndromes.

[1]  J. Toro,et al.  Hereditary Leiomyomatosis and Renal Cell Cancer , 2020, Handbook of Tumor Syndromes.

[2]  S. Sasidharanpillai,et al.  Muir-Torre syndrome , 2020, Definitions.

[3]  R. Scott,et al.  Dupuytren’s disease and the risk of malignant neoplasms , 2014, Hereditary cancer in clinical practice.

[4]  D. Mehregan,et al.  Cowden syndrome: report of two cases with immunohistochemical analysis for PTEN expression. , 2012, The American Journal of dermatopathology.

[5]  C. Zouboulis,et al.  New pharmaceutical concepts for sebaceous gland diseases: implementing today's pre-clinical data into tomorrow's daily clinical practice. , 2012, Current pharmaceutical biotechnology.

[6]  L. Aaltonen,et al.  Strong family history of uterine leiomyomatosis warrants fumarate hydratase mutation screening. , 2012, Human reproduction.

[7]  A. Fernandez-Flores.  Considerations on the Performance of Immunohistochemistry for Mismatch Repair Gene Proteins in Cases of Sebaceous Neoplasms and Keratoacanthomas With Reference to Muir–Torre Syndrome , 2012, The American Journal of dermatopathology.

[8]  C. Longo,et al.  Ameloblastoma: a neglected criterion for nevoid basal cell carcinoma (Gorlin) syndrome , 2012, Familial Cancer.

[9]  J. Mulliken,et al.  PTEN Hamartoma of Soft Tissue: A Distinctive Lesion in PTEN Syndromes , 2012, The American journal of surgical pathology.

[10]  A. Lazar,et al.  Trichilemmomas show loss of PTEN in Cowden syndrome but only rarely in sporadic tumors , 2012, Journal of cutaneous pathology.

[11]  Ming Zhou,et al.  Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome. , 2012, Urology.

[12]  Y. Yatabe,et al.  Pulmonary Cysts of Birt-Hogg-Dubé Syndrome: A Clinicopathologic and Immunohistochemical Study of 9 Families , 2012, The American journal of surgical pathology.

[13]  S. Seidenari,et al.  Brooke‐Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor‐suppressor genes , 2012, Journal of cutaneous pathology.

[14]  D. Evans,et al.  Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes , 2012, Acta Neuropathologica.

[15]  M. Kasper,et al.  Basal cell carcinoma - molecular biology and potential new therapies. , 2012, The Journal of clinical investigation.

[16]  C. Eng,et al.  Lifetime Cancer Risks in Individuals with Germline PTEN Mutations , 2012, Clinical Cancer Research.

[17]  P. Pontisso,et al.  APCI1307K Mutations and Forkhead Box Gene (FOXO1A): Another Piece of an Interesting Correlation , 2012, The International journal of biological markers.

[18]  E. Bongers,et al.  Renal cancer and pneumothorax risk in Birt–Hogg–Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families , 2011, British Journal of Cancer.

[19]  Poonam K Sharma,et al.  Renal medullary carcinomas: histopathologic phenotype associated with diverse genotypes. , 2011, Human pathology.

[20]  D. Cooper,et al.  Neurofibromatosis type 1-associated tumours: Their somatic mutational spectrum and pathogenesis , 2011, Human Genomics.

[21]  A. Bellizzi,et al.  Immunohistochemical Staining of Thyroidectomy Specimens for PTEN Can Aid in the Identification of Patients With Cowden Syndrome , 2011, The American journal of surgical pathology.

[22]  C. Eng,et al.  Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations. , 2011, The Journal of clinical endocrinology and metabolism.

[23]  P. Maxwell.  Seeing the smoking gun: a sensitive and specific method to visualize loss of the tumour suppressor, fumarate hydratase, in human tissues , 2011, The Journal of pathology.

[24]  A. Bree,et al.  Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS) , 2011, American journal of medical genetics. Part A.

[25]  L. Aaltonen,et al.  Aberrant succination of proteins in fumarate hydratase‐deficient mice and HLRCC patients is a robust biomarker of mutation status , 2011, The Journal of pathology.

[26]  S. Seidenari,et al.  Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas , 2011, Hereditary cancer in clinical practice.

[27]  E. Imyanitov,et al.  Drug therapy for hereditary cancers , 2011, Hereditary cancer in clinical practice.

[28]  M. Goetz,et al.  Colonic polyposis and neoplasia in Cowden syndrome. , 2011, Mayo Clinic proceedings.

[29]  G. Singh,et al.  Post-translational modifications of PTEN and their potential therapeutic implications. , 2011, Current cancer drug targets.

[30]  A. Rütten,et al.  Multiple (Familial) Trichoepitheliomas: A Clinicopathological and Molecular Biological Study, Including CYLD and PTCH Gene Analysis, of a Series of 16 Patients , 2011, The American Journal of dermatopathology.

[31]  E. Marqusee,et al.  Thyroid nodules and cancer in children with PTEN hamartoma tumor syndrome. , 2011, The Journal of clinical endocrinology and metabolism.

[32]  R. Benamouzig,et al.  Endoscopic findings in Cowden syndrome. , 2011, Endoscopy.

[33]  H. Lehtonen,et al.  Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics , 2011, Familial Cancer.

[34]  L. Thomas,et al.  Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma , 2011, Journal of Medical Genetics.

[35]  Salma K. Marani,et al.  Attitudes towards colorectal cancer screening in Lynch syndrome families: how do they change from pre-test genetic counseling to 6 and 12-months post-disclosure? , 2011, Hereditary Cancer in Clinical Practice.

[36]  J. Lasota,et al.  Succinate Dehydrogenase Subunit B (SDHB) Is Expressed in Neurofibromatosis 1-Associated Gastrointestinal Stromal Tumors (Gists): Implications for the SDHB Expression Based Classification of Gists , 2011, Journal of Cancer.

[37]  J. Tille,et al.  Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity. , 2011, Thyroid : official journal of the American Thyroid Association.

[38]  L. Hoefsloot,et al.  Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis , 2011, Clinical genetics.

[39]  C. Eng,et al.  Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. , 2010, Gastroenterology.

[40]  J. Lehmann-Che,et al.  Hereditary renal cancer syndromes: an update of a systematic review. , 2010, European urology.

[41]  A. V. D. van den Ouweland,et al.  Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis , 2010, Familial Cancer.

[42]  P. Driggers,et al.  Novel, orally active selective progesterone receptor modulator CP8947 inhibits leiomyoma cell proliferation without adversely affecting endometrium or myometrium , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[43]  Andrew Shenton,et al.  Basal Cell Carcinomas in Gorlin Syndrome: A Review of 202 Patients , 2010, Journal of skin cancer.

[44]  W. Weyers,et al.  Brooke-Spiegler Syndrome: Report of 10 Patients From 8 Families With Novel Germline Mutations: Evidence of Diverse Somatic Mutations in the Same Patient Regardless of Tumor Type , 2010, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[45]  Jean Kanitakis.  Adnexal tumours of the skin as markers of cancer‐prone syndromes , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[46]  C. Yeo,et al.  Periampullary and Duodenal Neoplasms in Neurofibromatosis Type 1: Two Cases and an Updated 20-Year Review of the Literature Yielding 76 Cases , 2010, Journal of Gastrointestinal Surgery.

[47]  Maria Laura De Marchis,et al.  Association between Birt Hogg Dube syndrome and cancer predisposition. , 2010, Anticancer research.

[48]  T. Vaněček,et al.  Brooke‐Spiegler syndrome: report of a case with a novel mutation in the CYLD gene and different types of somatic mutations in benign and malignant tumors , 2010, Journal of cutaneous pathology.

[49]  A. Enk,et al.  Entdeckung einer neuen Mutation im CYLD‐Gen bei einer Familie mit Brooke‐Spiegler‐Syndrom , 2010 .

[50]  A. Lazar,et al.  Sebaceous neoplasia and the Muir–Torre syndrome: important connections with clinical implications , 2010, Histopathology.

[51]  M. Skrzypczak,et al.  Multiple trichoepitheliomas – a novel mutation in the CYLD gene , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[52]  J. Frank,et al.  Clinical and molecular genetic aspects of hereditary multiple cutaneous leiomyomatosis. , 2009, European journal of dermatology : EJD.

[53]  T. Vaněček,et al.  A Case of Brooke-Spiegler Syndrome With a Novel Germline Deep Intronic Mutation in the CYLD Gene Leading to Intronic Exonization, Diverse Somatic Mutations, and Unusual Histology , 2009, The American Journal of dermatopathology.

[54]  T. Vaněček,et al.  Skin type spiradenoma of the parotid gland with malignant transformation: report of a case with analysis of the CYLD gene. , 2009, Human pathology.

[55]  J. Toro,et al.  Update of cylindromatosis gene (CYLD) mutations in Brooke‐Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling , 2009, Human mutation.

[56]  F. D. de Sauvage,et al.  Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. , 2009, Trends in pharmacological sciences.

[57]  A. Rütten,et al.  Morphologic Diversity of Malignant Neoplasms Arising in Preexisting Spiradenoma, Cylindroma, and Spiradenocylindroma Based on the Study of 24 Cases, Sporadic or Occurring in the Setting of Brooke-Spiegler Syndrome , 2009, The American journal of surgical pathology.

[58]  A. Zauber,et al.  Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial , 2009, Cancer Prevention Research.

[59]  A. Guimarães,et al.  PTCH1 isoforms in odontogenic keratocysts. , 2009, Oral oncology.

[60]  R. Pilarski.  Cowden Syndrome: A Critical Review of the Clinical Literature , 2009, Journal of Genetic Counseling.

[61]  W. Linehan,et al.  Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer. , 2008, Archives of dermatology.

[62]  J. Frank,et al.  Brooke–Spiegler syndrome complicated by unilateral hearing loss , 2008, International journal of dermatology.

[63]  P. Dennis,et al.  PTEN hamartoma tumor syndromes , 2008, European Journal of Human Genetics.

[64]  A. Lazar,et al.  Site and Tumor Type Predicts DNA Mismatch Repair Status in Cutaneous Sebaceous Neoplasia , 2008, The American journal of surgical pathology.

[65]  Stephen B Gruber,et al.  Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell cancer. , 2008, Cancer genetics and cytogenetics.

[66]  S. Seidenari,et al.  Wnt Pathway, Angiogenetic and Hormonal Markers in Sporadic and Familial Adenomatous Polyposis-associated Juvenile Nasopharyngeal Angiofibromas (JNA) , 2008, Applied immunohistochemistry & molecular morphology : AIMM.

[67]  M. Mahalingam,et al.  MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir–Torre syndrome , 2008, Modern Pathology.

[68]  L. Horev,et al.  CYLD mutations in familial skin appendage tumours , 2008, Journal of Medical Genetics.

[69]  P. Møller,et al.  Guidelines for the clinical management of familial adenomatous polyposis (FAP) , 2008, Gut.

[70]  M. Merino,et al.  The Morphologic Spectrum of Kidney Tumors in Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC) Syndrome , 2007, The American journal of surgical pathology.

[71]  E. Lucci-Cordisco,et al.  Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC , 2007, Clinical genetics.

[72]  C. Longo,et al.  BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-associated polyposis pedigrees. , 2007, The Journal of investigative dermatology.

[73]  B. Scheithauer,et al.  Low grade malignant peripheral nerve sheath tumor with smooth muscle differentiation , 2007, Acta Neuropathologica.

[74]  Ignacio Blanco,et al.  Conventional renal cancer in a patient with fumarate hydratase mutation. , 2007, Human pathology.

[75]  M. Novelli,et al.  An individual with Muir-Torre syndrome found to have a pathogenic MSH6 gene mutation , 2007, Familial Cancer.

[76]  Ximing J. Yang,et al.  Birt-Hogg-Dubé syndrome: clinicopathologic findings and genetic alterations. , 2006, Archives of pathology & laboratory medicine.

[77]  D. Evans,et al.  Guidelines for the diagnosis and management of individuals with neurofibromatosis 1 , 2006, Journal of Medical Genetics.

[78]  J. Hartley,et al.  Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling , 2006, Proceedings of the National Academy of Sciences.

[79]  S. Seidenari,et al.  Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas. , 2006, The Journal of investigative dermatology.

[80]  R. Szigeti,et al.  CYLD mutations underlie Brooke–Spiegler, familial cylindromatosis, and multiple familial trichoepithelioma syndromes , 2006, Clinical genetics.

[81]  Eero Pukkala,et al.  Analysis of fumarate hydratase mutations in a population‐based series of early onset uterine leiomyosarcoma patients , 2006, International journal of cancer.

[82]  G Pellacani,et al.  Attenuated familial adenomatous polyposis and Muir–Torre syndrome linked to compound biallelic constitutional MYH gene mutations , 2005, Clinical genetics.

[83]  L. Aaltonen,et al.  Increased risk of cancer in patients with fumarate hydratase germline mutation , 2005, Journal of Medical Genetics.

[84]  P. Choyke,et al.  Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer , 2005, Journal of Medical Genetics.

[85]  S. Seidenari,et al.  Different phenotypes in Muir–Torre syndrome: clinical and biomolecular characterization in two Italian families , 2005, The British journal of dermatology.

[86]  M. Fukayama,et al.  Gastrointestinal Stromal Tumors of Neurofibromatosis Type I (von Recklinghausen's Disease) , 2005, The American journal of surgical pathology.

[87]  M. Gill,et al.  Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial cylindromatosis, and multiple familial trichoepithelioma: lack of genotype-phenotype correlation. , 2005, The Journal of investigative dermatology.

[88]  R. Cusano,et al.  Molecular characterization of Italian nevoid basal cell carcinoma syndrome patients , 2005, Human mutation.

[89]  S. Seidenari,et al.  Identification of Muir–Torre syndrome among patients with sebaceous tumors and keratoacanthomas , 2005, Cancer.

[90]  A. Rowan,et al.  Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndrome. , 2005, Archives of dermatology.

[91]  C. Zouboulis.  Acne and sebaceous gland function. , 2004, Clinics in dermatology.

[92]  P. Propping,et al.  A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome , 2004, Journal of Medical Genetics.

[93]  L. Roncucci,et al.  Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas. , 2004, Pathology, research and practice.

[94]  P. Choyke,et al.  Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. , 2003, American journal of human genetics.

[95]  W. Linehan,et al.  Renal Tumors in the Birt-Hogg-Dubé Syndrome , 2002, The American journal of surgical pathology.

[96]  Maria Merino,et al.  Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. , 2002, Cancer cell.

[97]  S. Velasco-Miguel,et al.  Epidermal growth factor receptor signaling pathways are associated with tumorigenesis in the Nf1:p53 mouse tumor model. , 2002, Cancer research.

[98]  D. Evans,et al.  Malignant peripheral nerve sheath tumours in neurofibromatosis 1 , 2002, Journal of medical genetics.

[99]  P. Choyke,et al.  Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[100]  A. Paetau,et al.  Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer , 2002, Nature Genetics.

[101]  D. Gutmann,et al.  International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. , 2002, Cancer research.

[102]  C. Zouboulis,et al.  Chronological ageing and photoageing of the human sebaceous gland , 2001, Clinical and experimental dermatology.

[103]  N. Lindor,et al.  Cutaneous sinus tract of dental origin , 2001, International journal of dermatology.

[104]  J. Faivre,et al.  Colorectal adenocarcinoma in patients under 45 years of age: Comparison with older patients in a well-defined french population , 2001, Diseases of the colon and rectum.

[105]  L. Aaltonen,et al.  Inherited susceptibility to uterine leiomyomas and renal cell cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[106]  I. Tomlinson,et al.  Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genes , 2001, Gut.

[107]  A. King,et al.  Malignant peripheral nerve sheath tumors in neurofibromatosis 1. , 2000, American journal of medical genetics.

[108]  A. Ashworth,et al.  Identification of the familial cylindromatosis tumour-suppressor gene , 2000, Nature Genetics.

[109]  R. Gomez,et al.  PTCH Gene Mutations in Odontogenic Keratocysts , 2000, Journal of dental research.

[110]  M. Leppert,et al.  The identical 5' splice-site acceptor mutation in five attenuated APC families from Newfoundland demonstrates a founder effect , 1999, Human Genetics.

[111]  B. Korf,et al.  Structural anomalies revealed by neuroimaging studies in the brains of patients with neurofibromatosis type 1 and large deletions , 1999, Genetics in Medicine.

[112]  C. Has,et al.  [Multiple cutaneous cylindromas associated with parotid and submandibular gland cylindromas]. , 1998, Annales de dermatologie et de venereologie.

[113]  E. Telford,et al.  Characterisation of human patched germ line mutations in naevoid basal cell carcinoma syndrome , 1997, Human Genetics.

[114]  W. Bodmer,et al.  Allele loss in colorectal cancer at the Cowden disease/juvenile polyposis locus on 10q. , 1997, Cancer genetics and cytogenetics.

[115]  A. Goldstein,et al.  Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. , 1997, American journal of medical genetics.

[116]  D. Cooper,et al.  Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene , 1996, Human Genetics.

[117]  M. Scott,et al.  The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog , 1996, Nature.

[118]  R. Myers,et al.  Human Homolog of patched, a Candidate Gene for the Basal Cell Nevus Syndrome , 1996, Science.

[119]  E. Mariman,et al.  Localization of the gene for Cowden disease to chromosome 10q22–23 , 1996, Nature Genetics.

[120]  M. Stratton,et al.  Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12–q13: evidence for its role as a tumour suppressor gene , 1995, Nature Genetics.

[121]  L. Roncucci,et al.  Clinical and biologic features of adenomatosis coli in Northern Italy. , 1995, Scandinavian journal of gastroenterology.

[122]  G. Thomas,et al.  Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. , 1995, Human molecular genetics.

[123]  R. Hennekam,et al.  Dermal eccrine cylindromatosis. , 1994, Journal of medical genetics.

[124]  P. Propping,et al.  Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer , 1994, The Lancet.

[125]  D. Evans,et al.  Complications of the naevoid basal cell carcinoma syndrome: results of a population based study. , 1993, Journal of medical genetics.

[126]  P. Borgen,et al.  Cowden's disease. A case report with analyses at the molecular level , 1992, Cancer.

[127]  H. Järvinen.  Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival. , 1992, Gut.

[128]  G. Williams,et al.  Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen's disease) , 1991, Histopathology.

[129]  R. Martuza,et al.  Benign spinal nerve sheath tumors: their occurrence sporadically and in neurofibromatosis types 1 and 2. , 1991, Journal of neurosurgery.

[130]  D. Bardenstein,et al.  Cowden's disease. , 1988, Ophthalmology.

[131]  J. Cream,et al.  (59) Case for diagnosis: possible Cowden's disease (multiple hamartoma and neoplasia syndrome) , 1988 .

[132]  R. Browne,et al.  The odontogenic keratocyst and its occurrence in the nevoid basal cell carcinoma syndrome. , 1987, Oral surgery, oral medicine, and oral pathology.

[133]  F. Arwert,et al.  The Cowden syndrome: a clinical and genetic study in 21 patients , 1986, Clinical genetics.

[134]  H. Aram,et al.  Multiple hamartoma syndrome (Cowden's disease) , 1983, Journal of the American Academy of Dermatology.

[135]  B. Scheithauer,et al.  4 MALIGNANT PERIPHERAL NERVE SHEATH TUMORS WITH DIVERGENT DIFFERENTIATION , 1983 .

[136]  W. Steck,et al.  Cowden's disease (multiple hamartoma and neoplasia syndrome). A case report and review of the English literature. , 1983, Journal of the American Academy of Dermatology.

[137]  H. Lindeberg,et al.  [The nevoid basal cell carcinoma syndrome - Gorlin syndrome]. , 1980, Ugeskrift for laeger.

[138]  W. J. Dubé,et al.  Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. , 1977, Archives of dermatology.

[139]  L. Celli,et al.  [Gardner's syndrome]. , 1974, Minerva gastroenterologica.

[140]  P. Weary,et al.  Multiple hamartoma syndrome (Cowden's disease). , 1972, Archives of dermatology.

[141]  D. Stevanović.  Nevoid basal cell carcinoma syndrome. , 1967, Archives of dermatology.

[142]  E. Muir,et al.  Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato‐acanthomata of the face , 1967, The British journal of surgery.

[143]  Richard G. Frank,et al.  Archives of pathology , 1949 .

[144]  K. J. Franklin..  Acta Chirurgica Scandinavica. , 1930 .

[145]  S. West.  Recurrent Pneumothorax , 1889 .

[146]  R. Chamberlain,et al.  Neoplasms associated with germline and somatic NF1 gene mutations. , 2012, The oncologist.

[147]  A. Enk,et al.  New mutation in the CYLD gene within a family with Brooke-Spiegler syndrome. , 2010, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[148]  M. Leppert,et al.  Erratum: The identical 5' splice-site acceptor mutation in five attenuated APC families from Newfoundland demonstrates a founder effect (Human Genetics (1999) 105 (388-398)) , 2000 .

[149]  G. Chenevix-Trench,et al.  Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident. , 1997, American journal of human genetics.

[150]  P. O'Connell,et al.  Genomic organization of the neurofibromatosis 1 gene (NF1). , 1995, Genomics.

[151]  M. Anti,et al.  Cowden's disease with extensive gastrointestinal polyposis. , 1994, Journal of clinical gastroenterology.

[152]  M. P. Leòn,et al.  Hereditary gastrointestinal polyposis syndromes. , 1994, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[153]  Y. Nakamura,et al.  The role of the adenomatous polyposis coli (APC) gene in human cancers. , 1993, Advances in cancer research.

[154]  J. Woodruff,et al.  Glandular peripheral nerve sheath tumors. , 1993, Cancer.

[155]  B. Ponder,et al.  Inherited predisposition to cancer. , 1990, Trends in genetics : TIG.

[156]  S. Winawer,et al.  Early identification of individuals at increased risk for cancer of the large intestine. Part I: definition of high risk populations. , 1981, Clinical bulletin.

[157]  S. Winawer,et al.  Early identification of individuals at increased risk for cancer of the large intestine. Part II: development of risk factor profiles. , 1981, Clinical bulletin.

[158]  K. Ishak,et al.  Benign tumors and pseudotumors of the gallbladder. Report of 180 cases. , 1970, Archives of pathology.

[159]  M. Karno,et al.  Renal cell carcinoma. , 1956, Bulletin. Tufts-New England Medical Center.